Development and efficacy of a novobiocin-resistant Streptococcus iniae as a novel vaccine in Nile tilapia (Oreochromis niloticus)

Vaccine

Volumn 29, Issue 35, 2011, Pages 5986-5993

  Pridgeon, Julia W ^a   Klesius, Phillip H ^a  

^a AQUATIC ANIMAL HEALTH RESEARCH UNIT   (United States)

Author keywords

Nile tilapia; Streptococcal disease; Streptococcus iniae; Vaccine

Indexed keywords

NOVOBIOCIN; STREPTOCOCCUS INIAE VACCINE; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNITY; MALE; NONHUMAN; NOVOBIOCIN RESISTANCE; OREOCHROMIS NILOTICUS; PRIORITY JOURNAL; STREPTOCOCCUS INIAE; SURVIVAL; VACCINATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL VACCINES; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; FISH DISEASES; MALE; NOVOBIOCIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; SURVIVAL ANALYSIS; TILAPIA; VACCINATION; VACCINES, ATTENUATED; VIRULENCE;

EID: 79960745415     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.06.036     Document Type: Article

References (32)

1. Pier G.B., Madin S.H. Streptococcus iniae sp. nov., a beta-hemolytic Streptococcus isolated from an Amazon freshwater dolphin, Inia geoffrensis. Int J Syst Bacteriol 1976, 26:545-553.
2. Cheng S., Hu Y.H., Jiao X.D., Sun L. Identification and immunoprotective analysis of a Streptococcus iniae subunit vaccine candidate. Vaccine 2010, 28:2636-2641.
3. Eyngor M., Tekoah Y., Shapira R., Hurvitz A., Zlotkin A., Lublin A., et al. Emergence of novel Streptococcus iniae exopolysaccharide-producing strains following vaccination with nonproducing strains. Appl Environ Microbiol 2008, 74:6892-6897.
4. Agnew W., Barnes A.C. Streptococcus iniae: an aquatic pathogen of global veterinary significance and a challenging candidate for reliable vaccination. Vet Microbiol 2007, 122:1-15.
5. Ferguson H.W., St John V.S., Roach C.J., Willoughby S., Parker C., Ryan R. Caribbean reef fish mortality associated with Streptococcus iniae. Vet Rec 2000, 147:662-664.
6. Bromage E.S., Thomas A., Owens L. Streptococcus iniae, a bacterial infection in barramundi Lates calcarifer. Dis Aquat Organ 1999, 36:177-181.
7. Eldar A., Perl S., Frelier P.F., Bercovier H. Red drum Sciaenops ocellatus mortalities associated with Streptococcus iniae infection. Dis Aquat Organ 1999, 36:121-127.
8. Sun J.R., Yan J.C., Yeh C.Y., Lee S.Y., Lu J.J. Invasive infection with Streptococcus iniae in Taiwan. J Med Microbiol 2007, 56:1246-1249.
9. Koh T.H., Kurup A., Chen J. Streptococcus iniae discitis in Singapore. Emerg Infect Dis 2004, 10:1694-1696.
10. Weinstein M.R., Litt M., Kertesz D.A., Wyper P., Rose D., Coulter M., et al. Invasive infections due to a fish pathogen, Streptococcus iniae. S. iniae Study Group. N Engl J Med 1997, 337:589-594.
11. Shoemaker C.A., Lafrentz B.R., Klesius P.H., Evans J.J. Protection against heterologous Streptococcus iniae isolates using a modified bacterin vaccine in Nile tilapia, Oreochromis niloticus (L.). J Fish Dis 2010, 33:537-544.
12. Darwish A.M. Laboratory efficacy of florfenicol against Streptococcus iniae infection in sunshine bass. J Aquat Anim Health 2007, 19:1-7.
13. Eldar A., Horovitcz A., Bercovier H. Development and efficacy of a vaccine against Streptococcus iniae infection in farmed rainbow trout. Vet Immunol Immunopathol 1997, 56:175-183.
14. Bercovier H., Ghittino C., Eldar A. Immunization with bacterial antigens: infections with streptococci and related organisms. Dev Biol Stand 1997, 90:153-160.
15. Bachrach G., Zlotkin A., Hurvitz A., Evans D.L., Eldar A. Recovery of Streptococcus iniae from diseased fish previously vaccinated with a streptococcus vaccine. Appl Environ Microbiol 2001, 67:3756-3758.
16. Klesius P.H., Shoemaker C.A., Evans J.J. Efficacy of a killed Streptococcus iniae vaccine in tilapia (Oreochromis niloticus). Bull Eur Assoc Fish Pathol 1999, 19:39-41.
17. Klesius P.H., Shoemaker C.A., Evans J.J. Efficacy of single and combined Streptococcus iniae isolate vaccine administered by intraperitoneal and intramuscular routes in tilapia (Oreochromis niloticus). Aquaculture 2000, 188:237-246.
18. Klesius P.H., Evans J.J., Shoemaker C.A., Pasnik D.J. A vaccination and challenge model using calcein marked fish. Fish Shellfish Immunol 2006, 20:20-28.
19. Shoemaker C.A., Vandenberg G.W., Désormeaux A., Klesius P.H., Evans J.J. Efficacy of a Streptococcus iniae modified bacterin delivered using Oralject™ technology in Nile tilapia (Oreochromis niloticus). Aquaculture 2006, 255:151-156.
20. Locke J.B., Aziz R.K., Vicknair M.R., Nizet V., Buchanan J.T. Streptococcus iniae M-like protein contributes to virulence in fish and is a target for live attenuated vaccine development. PLoS One 2008, 3:e2824.
21. Buchanan J.T., Stannard J.A., Lauth X., Ostland V.E., Powell H.C., Westerman M.E., et al. Streptococcus iniae phosphoglucomutase is a virulence factor and a target for vaccine development. Infect Immun 2005, 73:6935-6944.
22. Klesius P.H., Shoemaker C.A. Development and use of modified live Edwardsiella ictaluri vaccine against enteric septicemia of catfish. Adv Vet Med 1999, 41:523-537.
23. Shoemaker C.A., Klesius P.H., Evans J.J. Immunization of eyed channel catfish, Ictalurus punctatus, eggs with monovalent Flavobacterium columnare vaccine and bivalent F. columnare and Edwardsiella ictaluri vaccine. Vaccine 2007, 25:1126-1131.
24. Kominek L.A. Biosynthesis of novobiocin by Streptomyces niveus. Antimicrob Agents Chemother 1972, 1:123-134.
25. Gellert M., O'Dea M.H., Itoh T., Tomizawa J. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase. Proc Natl Acad Sci USA 1976, 73:4474-4478.
26. Mdluli K., Ma Z. Mycobacterium tuberculosis DNA gyrase as a target for drug discovery. Infect Disord Drug Targets 2007, 7:159-168.
27. Shoemaker C.A., Arias C.R., Klesius P.H., Welker T.L. Technique for identifying Flavobacterium columnare using whole-cell fatty acid profiles. J Aqua Animal Health 2005, 17:267-274.
28. Amend D.F. Potency testing of fish vaccines. Dev Biol Stand 1981, 49:447-454.
29. McCallum N., Karauzum H., Getzmann R., Bischoff M., Majcherczyk P., Berger-Bächi B., et al. In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance. Antimicrob Agents Chemother 2006, 50:2352-2360.
30. Han F., Pu S., Wang F., Meng J., Ge B. Fitness cost of macrolide resistance in Campylobacter jejuni. Int J Antimicrob Agents 2009, 34:462-466.
31. Centers for Disease Control and Prevention (CDC), Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food-10 States, 2008 MMWR Morb Mortal Wkly Rep 2009;58:333-7.
32. Mehta M., Woo P.T. Acquired cell-mediated protection in rainbow trout, Oncorhynchus mykiss, against the haemoflagellate, Cryptobia salmositica. Parasitol Res 2002, 88:956-962.